PMID- 35346541 OWN - NLM STAT- MEDLINE DCOM- 20220428 LR - 20220727 IS - 1872-7131 (Electronic) IS - 0387-7604 (Linking) VI - 44 IP - 6 DP - 2022 Jun TI - Arterial spin labeling perfusion imaging in an infant with anti-N-methyl-D-aspartate receptor encephalitis: A case report. PG - 405-409 LID - S0387-7604(22)00038-9 [pii] LID - 10.1016/j.braindev.2022.03.001 [doi] AB - BACKGROUND: Anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis is an autoimmune encephalitis characterized by complex neuropsychiatric syndromes and the presence of cerebrospinal fluid (CSF) antibodies against NMDAR. The characteristics of anti-NMDAR encephalitis in children, particularly infants, are unclear due to difficulties in neurologic assessment such as psychiatric symptoms. Additionally, subtle or non-specific findings of conventional magnetic resonance imaging (MRI) make early diagnosis even more difficult. Herein, we present the first case of infant anti-NMDAR encephalitis in which perfusion imaging demonstrated marked abnormalities and the absence of conventional MRI findings. CASE PRESENTATION: The patient was an 11-month-old boy who was admitted because of seizure and prolonged fever. He presented with involuntary movements of the mouth and tongue. Brain MRI showed no morphological abnormalities, but three-dimensional arterial spin labeling (ASL) perfusion imaging showed reduced blood flow in the left temporal and frontal regions and the right cerebellum. After that, a positive anti-NMDAR antibody test result was received. Despite treatment with IVIG and methylprednisolone, the involuntary movements and autonomic dysfunction gradually became more prominent. After rituximab administration, the clinical symptoms improved slightly, and follow-up MRI revealed diffuse brain atrophy and improvement in the balance of brain perfusion. CONCLUSIONS: To the best of our knowledge, this is the first case report of infantile anti-NMDAR encephalitis in which cerebral blood flow was evaluated using three-dimensional ASL perfusion imaging. Indeed, our case, which showed abnormalities only in ASL perfusion imaging, suggests that CBF assessment could aid in the early diagnosis of anti-NMDAR encephalitis in infants. CI - Copyright (c) 2022 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved. FAU - Watanabe, Yuriko AU - Watanabe Y AD - Department of Pediatrics, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan. FAU - Sano, Fumikazu AU - Sano F AD - Department of Pediatrics, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan. Electronic address: fsano@yamanashi.ac.jp. FAU - Fukao, Toshimichi AU - Fukao T AD - Department of Pediatrics, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan. FAU - Shimizu, Tatsuya AU - Shimizu T AD - Department of Radiology, University of Yamanashi, Yamanashi, Japan. FAU - Sawanobori, Emi AU - Sawanobori E AD - Department of Pediatrics, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan. FAU - Kobayashi, Anna AU - Kobayashi A AD - Department of Pediatrics, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan. FAU - Fujioka, Kaoru AU - Fujioka K AD - Department of Pediatrics, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan. FAU - Yagasaki, Hideaki AU - Yagasaki H AD - Department of Pediatrics, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan. FAU - Inukai, Takeshi AU - Inukai T AD - Department of Pediatrics, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan. FAU - Kaga, Yoshimi AU - Kaga Y AD - Department of Pediatrics, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan. LA - eng PT - Case Reports DEP - 20220326 PL - Netherlands TA - Brain Dev JT - Brain & development JID - 7909235 RN - 0 (Receptors, N-Methyl-D-Aspartate) RN - 0 (Spin Labels) SB - IM MH - *Anti-N-Methyl-D-Aspartate Receptor Encephalitis/drug therapy MH - *Dyskinesias MH - Humans MH - Infant MH - Male MH - Perfusion MH - Perfusion Imaging MH - Receptors, N-Methyl-D-Aspartate MH - Spin Labels OTO - NOTNLM OT - Anti-N-methyl-d-aspartate receptor encephalitis OT - Arterial spin labelling perfusion OT - Autoimmune encephalitis OT - Magnetic resonance imaging COIS- Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. EDAT- 2022/03/30 06:00 MHDA- 2022/04/29 06:00 CRDT- 2022/03/29 05:42 PHST- 2021/08/30 00:00 [received] PHST- 2022/01/31 00:00 [revised] PHST- 2022/03/06 00:00 [accepted] PHST- 2022/03/30 06:00 [pubmed] PHST- 2022/04/29 06:00 [medline] PHST- 2022/03/29 05:42 [entrez] AID - S0387-7604(22)00038-9 [pii] AID - 10.1016/j.braindev.2022.03.001 [doi] PST - ppublish SO - Brain Dev. 2022 Jun;44(6):405-409. doi: 10.1016/j.braindev.2022.03.001. Epub 2022 Mar 26.